Severe acute respiratory syndrome (SARS) of humans is caused by a novel coronavirus of
zoonotic origin termed SARS-associated coronavirus (SARS-CoV). The virus induces …

Lymphopenia and increasing viral load in the first 10 days of severe acute respiratory
syndrome (SARS) suggested immune evasion by SARS-coronavirus (CoV). In this study, we …

Severe acute respiratory syndrome (SARS) caused by a novel human coronavirus (CoV),
designated SARS-CoV, is a highly contagious respiratory disease with the lungs as a major …

Severe acute respiratory syndrome (SARS), which is caused by a novel coronavirus (CoV),
is a highly communicable disease with the lungs as the major pathological target. Although …

The pathogenesis of severe acute respiratory syndrome (SARS) remains unclear.
Macrophages are key sentinel cells in the respiratory system, and it is therefore relevant to …

The clinical picture of severe acute respiratory syndrome (SARS) is characterized by
pulmonary inflammation and respiratory failure, resembling that of acute respiratory distress …

Background The SARS outbreak in 2003 provides a unique opportunity for the study of
human responses to a novel virus. We have previously reported that dendritic cells (DCs) …

Abstract Background SARS coronavirus (SARS-CoV) is the etiologic agent of the severe
acute respiratory syndrome. SARS-CoV mainly infects tissues of non-lymphatic origin, and …

The pathogenesis of severe acute respiratory syndrome (SARS) is poorly understood and
cytokine dysregulation has been suggested as one relevant mechanism to be explored. We …

Effective vaccines should confer long-term protection against future outbreaks of severe
acute respiratory syndrome (SARS) caused by a novel zoonotic coronavirus (SARS-CoV) …